None listed
Conditions
Brief summary
Gum disease is a very common oral disease that, if not treated, may cause tooth loss. The disease is caused by bacteria that build deposits on your teeth, above and below your gums. These are known as dental plaque and these may mineralise forming dental calculus (or tartar) on tooth surfaces. Management of gum disease requires an adequate level of self-performed teeth cleaning as well as professional intervention aimed at removing dental plaque and calculus. Although this treatment is effective for most teeth, challenges arise in the management of teeth that have multiple roots, such as molars. When gum disease has progressed to involve these teeth they can be harder to maintain long term. Air polishing is a treatment modality approved by the Australian Federal Government (TGA approved) and currently used in dental treatment. AIR-FLOW®’ is a specialized device that generates a spray of air, water and powder to aid in plaque removal without additional patient discomfort. This study aims to focus on its use on maintaining molar teeth with gum disease. The research has 3 main goals 1. Identify the impact of treatments on health/stability of gums around molar teeth. 2. Identifying the impact of treatments on the level of specific bacteria around molar teeth. 3. Determining how gum disease affects quality of life. It is anticipated that the air polishing will assist in reducing the level of specific bacteria around molar teeth and provide additional improvement in the stability of gum health.
Interventions
Adjunct use of erythritol powder air-polishing device (EPAP) in combination with conventional periodontal subgingival instrumentation (CPSI) alone during the initial non-surgical therapy of grade I, II and III furcations in patients with generalised stage II-IV periodontitis.
Treatments are to be undertaken under local anaesthesia and will be performed by a single periodontal specialist within a single appointment at a public dental clinic.
All participants will undergo full mouth CPSI accordi
Adjunct use of erythritol powder air-polishing device (EPAP) in combination with conventional periodontal subgingival instrumentation (CPSI) alone during the initial non-surgical therapy of grade I, II and III furcations in patients with generalised stage II-IV periodontitis. Treatments are to be undertaken under local anaesthesia and will be performed by a single periodontal specialist within a single appointment at a public dental clinic. All participants will undergo full mouth CPSI according to their clinical periodontal treatment plan. This will consist of subgingival debridement using the piezo device included in the PROPHYLAXIS MASTER (AIR-FLOW® PROPHYLAXIS MASTER) followed by hand instrumentation using curettes (Hu-Friedy, Chicago, Illinois, USA). CPSI will conclude, including at subject sites, when the operator considers the surfaces sufficiently clean and free of deposits. Participants allocated to the test group using the AIR-FLOW® PROPHYLAXIS MASTER in combination with erythritol powder (AIR FLOW® Powder PLUS, mean grain size 14um, 0.3% chlorhexidine). At the beginning of the treatment all sites in test subjects will be treated with the AIR-FLOW® handpiece using the spray-painting stroke technique. Any pocket greater than or equal to 5mm, including furcation test sites will be treated with the PERIO-FLOW® handpiece in combination with a flexible disposable nozzle (PERIO-FLOW® Nozzle) using vertical overlapping strokes for ~5 seconds per surface. Powder settings to be used are 70% (AIR-FLOW®) and 50% (PERIO-FLOW®) and the water setting will be set to 80%. The approximate duration of the intervention will be two, 60 minute appointments. Patient dental records will be used to monitor adherence to the intervention.
Sponsors
Tihanna Divnic-Resnik
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients with generalised periodontitis stage II, III and/or IV with affected furcations (horizontal grade I, II and III) in mandibular first and second molars (must be vital teeth). 2. Age range: greter than or equal to 18 years. 3. Patients in good systemic health (ASA class 1 and 2). 4. Willingness to provide informed consent and willingness to participate and comply with the study requirements and protocol. 5. Patients who have not been treated for periodontal diseases in the previous 6 months and who are not currently receiving/undergoing periodontal therapy. 6. Patients that are not currently involved in periodontal supportive program (SPT). 7. Women of childbearing potential who are using a reliable contraceptive method(s).
Exclusion criteria
1. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study. 2. Participants currently experiencing psychological illness or other conditions which may interfere with their ability to understand the study requirements or interfere with their motivation to participate in the study. 3. Participants with a history of active periodontal treatment (subgingival instrumentation) in the previous 6 months. 4. Participants who have taken antibiotics within the past 3 months. 5. Patients taking non-steroidal anti-inflammatory medications or those who were on these medications in the past 4 weeks. 6. Patients who received any acute treatment or had acute diseases in previous 4 weeks. 7. Participants with a history of any serious and uncontrolled systemic diseases (ASA class 3-6). 8. Participants on supportive periodontal therapy. 9. Participants unable to obtain sufficient level of oral hygiene for successful treatment outcomes
Outcome results
None listed